Back to Directory
Last Updated: 03/06/2026
Minaris Advanced Therapies
London
Founded 2025
Global cell and gene therapy CDMO
Minaris Advanced Therapies is a company providing contract development, manufacturing and testing services across the cell and gene therapy lifecycle.
Its UK operations originate from the former Oxgene business, contributing proprietary AAV and lentiviral manufacturing technologies.
In December 2025 the company relocated its viral vector innovation centre to the CGT Catapult's collaborator laboratories in London.
Formed in May 2025 through the merger of Minaris Regenerative Medicine and WuXi Advanced Therapies under US investment firm Altaris.